NCT04451161 A Hybrid Type 2 Trial of Trauma-Focused Cognitive Behavioral Therapy and a Pragmatic Individual-Level Implementation Strategy Status COMPLETED Phase NA
NCT04450654 Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial) Status WITHDRAWN Phase PHASE2
NCT04450212 Vitamin K Supplementation Study in Healthy Volunteers (Aim 2B) Status TERMINATED Phase NA
NCT04442581 Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer Status TERMINATED Phase PHASE2
NCT04437290 University of Washington Alzheimer's Disease Research Center (UW ADRC) Imaging & Biomarker Core Status UNKNOWN Phase N/A
NCT04435873 Assessing Patient-Reported Experience of Care for Home Dialysis (ASPIRED) Status COMPLETED Phase N/A
NCT04427202 Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC) Status COMPLETED Phase NA
NCT04407611 Scalable Communication Modalities for Returning Genetic Research Results Status COMPLETED Phase NA
NCT04403139 VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04387227 Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT04383743 Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer Status COMPLETED Phase PHASE2